Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine

Brain Research

Volumn 863, Issue 1-2, 2000, Pages 112-119

  Werme, Martin ^a   Ringholm, Aneta ^a   Olson, Lars ^a   Brené, Stefan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

In situ hybridization; Neuroleptics; NR4A1; NR4A2; NR4A3; Nuclear orphan receptor; Schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; NUCLEAR PROTEIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PUTAMEN; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DNA-BINDING PROTEINS; DRUG ADMINISTRATION SCHEDULE; HALOPERIDOL; IN SITU HYBRIDIZATION; MALE; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, DOPAMINE D2; RECEPTORS, STEROID; RNA, MESSENGER; SCHIZOPHRENIA; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0034724804     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02109-0     Document Type: Article

References (31)

1. S. Brene, C. Messer, E.J. Nestler, Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol, Neuroscience 84 (1998) 813-823.
2. K. Cauley, M. Marks, L.C. Gahring, S.W. Rogers, Nicotinic receptor subunits alpha 3, alpha 4, and beta 2 and high affinity nicotine binding sites are expressed by P19 embryonal cells, J. Neurobiol. 30 (1996) 303-314.
3. R. Cervini, S. Berrard, S. Bejanin, J. Mallet, Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters, NeuroReport 5 (1994) 1346-1348.
4. T. Curran, M.B. Gordon, K.L. Rubino, L.C. Sambucetti, Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro, Oncogene 2 (1987) 79-84.
5. A. Dagerlind, K. Friberg, A.J. Bean, T. Hökfelt, Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry, Histochemistry 98 (1992) 39-49.
6. M. Dragunow, G.S. Robertson, R.L. Faull, H.A. Robertson, K. Jansen, D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons, Neuroscience 37 (1990) 287-294.
7. L. Farde, A.L. Nordström, F.A. Wiesel, S. Pauli, C. Halldin, G. Sedvall, Positron emission tomographic analysis of central Dl and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiatry 49 (1992) 538-544.
8. L.W Fitzgerald, A.Y. Deutch, G. Gasic, S.F. Heinemann, E.J. Nestler, Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs, J. Neurosci. 15 (1995) 2453-2461.
9. B.M. Forman, K. Umesono, J. Chen, R.M. Evans, Unique response pathways are established by allosteric interactions among nuclear hormone receptors, Cell 81 (1995) 541-550.
10. C. Garner, M. Kelly, L. Cardon, G. Joslyn, A. Carey, C. LeDuc, J. Lichter, T. Harris, J. Loftus, G. Shields, M. Comazzi, A. Vita, A.M. Smith, J. Dann, T.J. Crow, L.E. DeLisi, Linkage analyses of schizophrenia to chromosome 6p24-p22: an attempt to replicate, Am. J. Med. Genet. 67 (1996) 595-610.
11. A.B. Goodman, Three independent lines of evidence suggest retinoids as causal to schizophrenia, Proc. Natl. Acad. Sci. USA 95 (1998) 7240-7244.
12. T.A. Kosten, J.L. DeCaprio, E.J. Nestler, Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure, Psychopharmacology 128 (1996) 304-312.
13. T.A. Kosten, E.J. Nestler, Clozapine attenuates cocaine conditioned place preference, Life Sci. 55 (1994) PL9-14.
14. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R.M. Evans, The nuclear receptor superfamily: the second decade, Cell 83 (1995) 835-839.
15. J. Milbrandt, Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene, Neuron 1 (1988) 183-188.
16. N. Ohkura, M. Hijikuro, A. Yamamoto, K. Miki, Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells, Biochem. Biophys. Res. Commun. 205 (1994) 1959-1965.
17. K. Okuse, I. Matsuoka, K. Kurihara, Tissue-specific methylation occurs in the essential promoter element of the tyrosine hydroxylase gene, Brain Res. Mol. Brain Res. 46 (1997) 197-207.
18. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
19. T. Perlmann, L. Jansson, A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1, Genes Dev. 9 (1995) 769-782.
20. G.S. Robertson, H.C. Fibiger, Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine, Neuroscience 46 (1992) 315-328.
21. G.S. Robertson, H. Matsumura, H.C. Fibiger, Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity, J. Pharmacol. Exp. Ther. 271 (1994) 1058-1066.
22. T.A. Samad, W. Krezel, P. Chambon, E. Borrelli, Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family, Proc. Natl. Acad. Sci. USA 94 (1997) 14349-14354.
23. S.G. Schwab, M. Albus, J. Hallmayer, S. Honig, M. Borrmann, D. Lichtermann, R.P. Ebstein, M. Ackenheil, B. Lerer, N. Risch et al., Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis, Nat. Genet. 11 (1995) 325-327.
24. R.E. Straub, C.J. MacLean, F.A. O'Neill, J. Burke, B. Murphy, F. Duke, R. Shinkwin, B.T. Webb, J. Zhang, D. Walsh et al., A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity [see comments], Nat. Genet. 11 (1995) 287-293.
25. J.M. van Rossum, The significance of dopamine receptor blockade for mechanism of action of neuroleptic drugs, Arch. Int. Pharmacodyn. Ther. 160 (1966) 492-494.
26. M. Werme, P. Thorén, L. Olson, S. Brené, Addiction-prone Lewis but not Fischer rats develop compulsive running that coincides with downregulation of nerve growth factor inducible-B and neuron-derived orphan receptor 1, J. Neurosci. 19 (1999) 6169-6174.
27. M. Werme, L. Olson, S. Brené, NGFI-B and Nor1 mRNAs are upregulated in brain reward pathways by drugs of abuse: different effects in Fischer and Lewis rats. Mol. Brain Res. 2000 (in press).
28. T.E. Wilson, T.J. Fahrner, M. Johnston, J. Milbrandt, Identification of the DNA binding site for NGFI-B by genetic selection in yeast, Science 252 (1991) 1296-1300.
29. T.E. Wilson, T.J. Fahrner, J. Milbrandt, The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction, Mol. Cell. Biol. 13 (1993) 5794-5804.
30. D.P. Younkin, C.M. Tang, M. Hardy, U.R. Reddy, Q.Y. Shi, S.J. Pleasure, V.M. Lee, D. Pleasure, Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line, Proc. Natl. Acad. Sci. USA 90 (1993) 2174-2178.
31. R.H. Zetterström, L. Solomin, L. Jansson, B.J. Hoffer, L. Olson, T. Perlmann, Dopamine neuron agenesis in Nurr1-deficient mice, Science 276 (1997) 248-250.